Invest now
Sai Life Sciences share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹1,595.60(-4.75%)September 10, 2026 15:29:59 PM IST
- NSE
- BSE
- Vol : 1.21 M (NSE + BSE)Last 20 day avg : 786.32 K
Sai Life Sciences is trading -4.75% lower at Rs 1,595.60 as compared to its last closing price. Sai Life Sciences has been trading in the price range of 1,679.85 & 1,587.00. Sai Life Sciences has given 84.43% in this year & 5.57% in the last 5 days. Sai Life Sciences has TTM P/E ratio 71.88 as compared to the sector P/E of 44.57.There are 4 analysts who have initiated coverage on Sai Life Sciences. There are 2 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 73.29 Crores in its last quarter.Listed peers of Sai Life Sciences include Sun Pharmaceutical Industries (-0.24%), Divi's Laboratories (-0.82%), Torrent Pharmaceuticals (-0.07%).The Mutual Fund holding in Sai Life Sciences was at 29.47% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Sai Life Sciences was at 19.65% in 30 Jun 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 11 Sep 2026, 12:47 AM IST
- Debt To EquityHigher than industry0.12The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.44The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Sai Life Sciences News
Sai Life Sciences Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,864.00 | -0.24 | 4,47,225.50 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,405.00 | -0.82 | 2,49,673.20 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,928.40 | -0.07 | 1,87,598.34 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,380.00 | 0.88 | 1,11,484.47 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,118.00 | -0.97 | 1,11,520.93 | 21.19 | 4.24 | 0.09 | 14.22 |
Mutual Fund Ownership
View allSai Life Sciences Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-14 | Audited Results |
| 2026-02-05 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
About the company Sai Life Sciences
- IndustryBiotechnology & Drugs
- ISININE570L01029
- BSE Code544306
- NSE CodeSAILIFE
Sai Life Sciences Limited is an India-based company. The Company is a contract research, development, and manufacturing organization (CRDMO). It offers a range of tailor-made services for biotech firms or global pharma company requirements. Its services include integrated drug discovery services, drug metabolism and pharmacokinetics (DMPK), synthetic & medicinal chemistry, biology services, general toxicology, genotoxicity, and computational chemistry services. It also offers chemistry, manufacturing and controls (CMC) services which include route scouting, process familiarization, optimization & development, analytical method development & validation, process safety evaluation, stability studies, and early phase scale-up. Its discovery biology facility provides exploratory biology services to the expanding array of start-up and biotech companies in the Boston area and to companies in North America.
Sai Life Sciences Share Price FAQs
Sai Life Sciences is trading at 1595.60 as on Thu Sep 10 2026 09:59:59. This is -4.75% lower as compared to its previous closing price of 1675.15.
The market capitalization of Sai Life Sciences is 33944.59 Cr as on Thu Sep 10 2026 09:59:59.
The average broker rating on Sai Life Sciences is Strong Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Sai Life Sciences is 1697.00 whereas the 52 wk low is 786.15
Sai Life Sciences can be analyzed on the following key metrics -
- TTM P/E: 71.88
- Sector P/E: 44.57
- Dividend Yield: 0.00%
- D/E ratio: -
Sai Life Sciences reported a net profit of 348.91 Cr in 2026.
The Mutual Fund Shareholding was 29.47% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Sai Life Sciences QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.